Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Less Steps, More Vision

The Liberty® trifocal (677MY/677MTY) presbyopia correcting IOL was designed based on optical principles and ocular physiology to deliver an expanded range of quality uncorrected vision.

Learn more about the novel features of this IOL and its performance in clinical practice.

Elevated Phase Shift (EPS) technology is Medicontur’s proprietary and patented approach to trifocality that both optimizes trifocal performance and light energy utilization.

Data presented from bench simulation studies show how the EPS optic design distributes light intensity to where it is needed most to optimize vision across a range of distances for varying pupil sizes.

Outcomes of defocus curve measurements from clinical studies of the Liberty trifocal IOL conducted by different investigators confirmed that EPS technology provides an expanded range of functional uncorrected vision.

In addition, the surgeons share evidence showing how their patients benefited from improvements in contrast sensitivity and night-time dysphotopsias compared with their preoperative experience.

Discover more about the material and design features of the Liberty trifocal IOL’s Bi-Flex platform that contributes to predictable and stable refractive and visual outcomes by ensuring and maintaining proper fixation within the capsular bag and preventing posterior capsule opacification.

More information

>Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Ophthalmologist site. It’s FREE!

Login
Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Company Information

Related Case Study
Uncovering Ocular Comorbidity

| Contributed by Quidel

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register